Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits

被引:117
|
作者
Hirano, T
Burr, DB [1 ]
Turner, CH
Sato, M
Cain, RL
Hock, JM
机构
[1] Indiana Univ, Sch Med, Dept Anat, Biomech & Biomat Res Ctr, Indianapolis, IN 46285 USA
[2] Indiana Univ, Sch Med, Dept Orthoped Surg, Biomech & Biomat Res Ctr, Indianapolis, IN 46285 USA
[3] Lilly Res Labs, Indianapolis, IN USA
关键词
D O I
10.1359/jbmr.1999.14.4.536
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intermittent administration of parathyroid hormone (PTH) has an anabolic effect in cancellous bone of osteoporotic humans. However, the effect of PTH on cortical bone with Haversian remodeling remains controversial. The aim of this study was to determine the effects of biosynthetic human PTH(1-34) on the histology and mechanical properties of cortical bone in rabbits, which exhibit Haversian remodeling. Mature New Zealand white rabbits were treated with once daily injections of vehicle, or PTH(1-34), LY333334, at 10 mu g/kg/day or 40 mu g/kg/day for 140 days. Bodyweight in rabbits treated with PTH did not change significantly over the experimental period. Serum calcium and phosphate were within the normal range, but a 1 mg/ml increase in serum calcium was observed in rabbits given the higher dose of PTH. Histomorphometry of cortical bone in the midshaft of the tibia showed significant increases in periosteal and endocortical bone formation in these rabbits, Intracortical bone remodeling in the tibia was activated and cortical porosity increased by PTH. Cross-sectional bone area and bone mass of the midshaft of the femur increased significantly after PTH treatment. Ultimate force, stiffness, and work to failure of the midshaft of the femur of rabbits given the 40 mu g dose of PTH were significantly greater than those in the control group, whereas elastic modulus was as significantly tower than that in the rabbits given the 10 pg dose of PTH, but not different from controls. In the third lumbar vertebra, PTH increased both formation and resorption without increasing cancellous bone volume. The increases in bone turnover and cortical porosity were accompanied hy concurrent increases in bone at the periosteal and endocortical surfaces. The combination of these phenomena resulted in an enhancement of the ultimate stress, stiffness, and work to failure of the femur.
引用
收藏
页码:536 / 545
页数:10
相关论文
共 50 条
  • [1] Early effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling and mechanical properties of cortical bone in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) : 804 - 804
  • [2] Effects of human parathyroid hormone (1-34), LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle in rabbits
    Mashiba, T
    Burr, DB
    Turner, CH
    Sato, M
    Cain, RL
    Hock, JM
    [J]. BONE, 2001, 28 (05) : 538 - 547
  • [3] In vivo and in vitro comparison of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), with synthetic hPTH(1-34).
    Black, EC
    Frolik, CA
    Hock, JM
    Cain, RL
    Chandrasekhar, S
    Harvey, AK
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F370 - F370
  • [4] Pharmacokinetic profile of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), and serum biochemistry after anabolic or catabolic injection protocols.
    Frolik, CA
    Black, EC
    Cain, RL
    Hock, JM
    Osborne, JJ
    Satterwhite, JH
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F371 - F371
  • [5] Assessment of effects of LY333334 [recombinant human parathyroid hormone (1-34)] on cortical bone using digital X-ray radiogrammetry.
    Hyldstrup, L
    Jorgensen, JT
    Gaich, G
    [J]. BONE, 2001, 28 (05) : S97 - S98
  • [6] Effects of LY333334 [recombinant parathyroid hormone (1-34)] on cortical bone strength indices as assessed by peripheral quantitative computed tomography.
    Zanchetta, JR
    Bogado, C
    Ferretti, JL
    Wang, O
    Sato, M
    Gaich, GA
    [J]. BONE, 2001, 28 (05) : S86 - S86
  • [7] Effects of LY333334 [recombinant human parathyroid hormone (1-34)] and alendronate sodium on markers of bone metabolism in postmenopausal women with osteoporosis.
    Body, JJ
    Gaich, GA
    Scheele, WH
    Kulkarni, PM
    Hodsman, AB
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 : S530 - S530
  • [8] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys
    Brommage, R
    Hotchkiss, CE
    Lees, CJ
    Stancill, MW
    Hock, JM
    Jerome, CP
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10): : 3757 - 3763
  • [9] Mechanical loading enhances the anabolic effects of intermittent parathyroid hormone (1-34) on trabecular and cortical bone in mice
    Sugiyama, Toshihiro
    Saxon, Leanne K.
    Zaman, Gul
    Moustafa, Alaa
    Sunters, Andrew
    Price, Joanna S.
    Lanyon, Lance E.
    [J]. BONE, 2008, 43 (02) : 238 - 248
  • [10] Regulation of caspase activity in trabecular bone of young rats treated once daily with human parathyroid hormone, rhPTH 1-34, (LY333334) for up to 6 days.
    Stanislaus, D
    Cain, RL
    Hock, JM
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S286 - S286